Difference between revisions of "User:Shawndouglas/sandbox/sublevel34"
Shawndouglas (talk | contribs) |
Shawndouglas (talk | contribs) |
||
Line 57: | Line 57: | ||
|- | |- | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Arkansas | | style="background-color:white; padding-left:10px; padding-right:10px;"|[https://www.healthy.arkansas.gov/programs-services/topics/epidemiology Arkansas] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|N | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Y (?) | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|[https://www.healthy.arkansas.gov/images/uploads/pdf/CommunicableDiseaseReportingForm.pdf Communicable Disease Reporting Form] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Phone: (501) 537-8969 or 1-800-554-5738 after-hours | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Arkansas Department of Health doesn't appear to have published any information about specific COVID-19 reporting requirements. The DoH is [https://www.healthy.arkansas.gov/images/uploads/pdf/List_and_Instructions_Reportable_Diseases.pdf presumably] treating "suspected or confirmed" COVID-19 cases as an immediately reportable event that "are to be reported immediately to the ADH," via telephone. The language used on its reportable disease instructions suggests that a follow-up fax of the case report isn't required; however, call and confirm with the DoH. The DoH disease reporting web page makes no mention of ELR. | ||
|- | |- | ||
|- | |- | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"|California | | style="background-color:white; padding-left:10px; padding-right:10px;"|[https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/Reportable-Disease-and-Conditions.aspx California] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Y | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|N (?) | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|[https://www.cdph.ca.gov/CDPH%20Document%20Library/ControlledForms/cdph110a.pdf Confidential Morbidity Report] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Contact: [https://www.cdph.ca.gov/Programs/CCLHO/Pages/CCLHO-Health-Officer-Directory.aspx Local health officers]<br /> <br />CalREDIE: CalREDIEHelp@cdph.ca.gov or (866) 866-1428 | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|The DPH [https://www.cdph.ca.gov/Programs/OSPHLD/LFS/CDPH%20Document%20Library/LFSCOVID19ltr-1.pdf has added] COVID-19 to its Reportable Diseases and Conditions lists for [https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/ReportableDiseases.pdf health care providers] and [https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/LabReportableDiseases.pdf laboratories]. This health care provider document indicates that a "case or suspected case" of COVID-19 should be reported immediately by phone. The document makes no mention of requiring a follow-up fax or digital report by health care providers. The laboratory document indicates "[l]aboratories must report any initial findings as well as any subsequent findings. "Any laboratories approved to test for SARS-CoV-2 must report all positive and non-positive (negative, indeterminate, and specimen unsatisfactory) test results from both antigen/molecular and antibody/serology tests for SARS-CoV-2." Laboratory findings are "are reportable to the local health officer of the health jurisdiction where the patient resides by telephone within one (1) hour ... from the time that the laboratory notifies the health care provider or other person authorized to receive the report." Labs are asked to also subsequently report results electronically (ELR) to the California Reportable Disease Information Exchange (CalREDIE) "within one working day of identification." | ||
|- | |- | ||
Line 102: | Line 102: | ||
|- | |- | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"|District of Columbia | | style="background-color:white; padding-left:10px; padding-right:10px;"|[https://dchealth.dc.gov/service/infectious-diseases District of Columbia] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|N | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Y | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|No standardized COVID-19 reporting form | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Phone: (202) 442-8141 or 1-(844)-493-2652 after-hours<br /> <br />Fax: (202) 442-8060 | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|DC Health doesn't appear to have published any information about specific COVID-19 reporting requirements. The DoH is [https://dchealth.dc.gov/sites/default/files/dc/sites/doh/publication/attachments/Notifiable%20Diseases%20and%20Conditions%20in%20DC%20v20180327.pdf presumably] treating COVID-19 tests with "provisional diagnosis or the appearance of suspicious symptoms" as an immediately reportable event that "must be reported immediately by telephone ... and confirmed by submission of a case report within 24 hours." ELR appears to be reserved for specific diseases other than COVID-19. | ||
|- | |- | ||
Line 466: | Line 466: | ||
|- | |- | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Wisconsin | | style="background-color:white; padding-left:10px; padding-right:10px;"|[https://www.dhs.wisconsin.gov/disease/diseasereporting.htm Wisconsin] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Y | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Y | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|[https://www.dhs.wisconsin.gov/forms/f4/f44151.docx Acute and Communicable Disease Case Report F-44151] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Contact: [https://www.dhs.wisconsin.gov/lh-depts/counties/index.htm Local health department]<br /> <br />WEDSS: DHSWEDSS@wisconsin.gov | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|"The state epidemiologist has declared COVID-19 a Category I reportable disease per a memo issued on Feb. 4, 2020. Report immediately by telephone to the patient's local public health department upon identification of a confirmed or suspected case. The local health department shall then notify the state epidemiologist immediately of any confirmed or suspected cases. Within 24 hours, submit a case report electronically through the Wisconsin Electronic Disease Surveillance System (WEDSS), by mail or fax using an Acute and Communicable Disease case report, F44151 or by other means." | ||
|- | |- | ||
|- | |- | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Wyoming | | style="background-color:white; padding-left:10px; padding-right:10px;"|[https://health.wyo.gov/publichealth/infectious-disease-epidemiology-unit/reporting/ Wyoming] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|N | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Y | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|[https://health.wyo.gov/wp-content/uploads/2016/04/22-12940_FillinDiseaseReportForm_2012.pdf Confidential Disease Report form] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|Phone: 1-888-996-9104<br /> <br />Fax: (307) 777-5573 | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | | style="background-color:white; padding-left:10px; padding-right:10px;"|"Providers and laboratories must report positive [SARS-CoV-2] laboratory tests from commercial reference laboratories to WDH by faxing copies of the laboratory report form to 307-777-5573." According to Wyoming's [https://health.wyo.gov/wp-content/uploads/2020/04/2020ReportableListrevised-1.pdf Reportable Diseases and Conditions List], this faxed report would be in addition to immediate notification by phone. Additionally, "[h]ospital and reference labs with ELR capacity must report positive and negative results," as well as viral detection and serology results. According to that document, COVID-19 isn't a disease preferred for ELR. | ||
|- | |- | ||
Revision as of 20:23, 24 April 2020
3. Workflow and information management for COVID-19 (and other pandemics)
3.1 Laboratory informatics and workflow management
3.2 Laboratory informatics and reporting requirements
Epidemiology can broadly be split into two categories: descriptive epidemiology and analytical epidemiology. Descriptive epidemiology involves studies and other activites that deal with geographical comparisons and temporal trend descriptions of disease. As such, the collection and use of quality incidence data is vital to developing hypotheses.[1] Analytical epidemiology allows for the testing of those hypotheses using both experimental and obsevational studies, as well as control groups. Similarly, the collection and use of quality experimental and observational data is vital for proving or disproving hypotheses.[2] In both cases, proper reporting of data is critical to the success of epidemiologists' response to outbreaks and pandemics, as well as the credibility of their research.[3][4]
The proper reporting of COVID-19 case data is no exception. In the United States, the CDC has taken a standardized approach to collecting reports on "individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19."[5] Their COVID-19 Case Report Form is designed to collect a wide variety of information about a COVID-19 case, including patient demographics, epidemiological characteristics, exposure and contact history, and clinical diagnosis and treatment procedures. Currently, the CDC is asking local and state health departments to submit case reports, and asking healthcare providers to contact those health departments when "concerned that a patient may have COVID-19." The CDC has also slimmed its reporting requirements, limiting reporting of "persons under investigation" to areas where testing must be forwarded to the CDC due to insufficient capacity to test locally.[5] Electronic reporting using the CDC's system is preferred, but they have a protocol for those areas unable to submit electronically. Canada has similar reporting expectations, with their own case report form and electronic data submission process through the Public Health Agency of Canada.[6] And in the European Union, member countries and the U.K. are asked to report through the Early Warning and Response System.[7]
Somewhat related are any internal reporting requirements, particularly for test reporting in labs and medical facilities. The International Statistical Classification of Diseases and Related Health Problems (ICD) is a system of diagnostic codes for classifying diseases, including nuanced classifications of a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or disease. Their ICD-10-CM code set has been modified to include lab testing codes for COVID-19, as has the Current Procedural Terminology (CPT) code set. Green and Bradley provide insight into these additions[8], as does the American Academy of Pediatrics.[9]
Laboratories analyzing specimens for SARS-CoV-2 therefore must be equipped to not only handle analytical testing and test orders using the new test codes, but they also must be able to quickly and accurately transfer vital case information to the appropriate health authority.
|
3.3 Additional benefits of laboratory informatics in disease testing and public health
In a 2013 research paper published in the journal BMJ Quality & Safety, El-Kareh et al. analyzed and described the state of diagnostic health information technology (HIT). They noted that without the aid of HIT, clinicians are more error-prone, leaving them "vulnerable to fallible human memory, variable disease presentation, clinical processes plagued by communication lapses, and a series of well-documented ‘heuristics,’ biases, and disease-specific pitfalls."[10] Appropriate, well-designed HIT systems are capable of helping clinicians and laboratorians by providing more timely access to information, improved communication, better clinical reasoning and decision making, and improved workflows, as well as a reduction in diagnostic errors, and, as a result, improved patient safety and health outcomes.[11]
From a public health perspective, the application of informatics to disease surveillance, reporting, and health promotion is also vital. Winters-Miner et al. note in particular the value of using informatics tools and methods to implement predictive analytics and data mining into public health. They use disease prevention and biosurveillance as major examples. We could, for example "analyze large populations of people to quantify risks related to public health, and help physicians to develop intervention programs for those patients at highest risk of some ailment or medical condition."[12] Additionally, through the use of syndromic surveillance systems (tools aiding in the detection of indicators leading up to disease diagnosis for individuals and populations[13]), they suggest that outbreaks can be better detected at local and national levels, and public health measures can be better implemented, increasing public awareness and hindering the spread of disease.[12]
https://www.nature.com/articles/s41746-019-0110-4 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204239/ https://www.nap.edu/read/21794/chapter/7#241 https://www.mlo-online.com/home/article/13017228/poct-made-easier-with-informatics
3.3.1 Bioinformatics
References
- ↑ Naito, M. (2014). "Utilization and application of public health data in descriptive epidemiology". Journal of Epidemiology 24 (6): 435–6. doi:10.2188/jea.je20140182. PMC PMC4213216. PMID 25327184. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213216.
- ↑ Centers for Disease Control and Prevention (2012) (PDF). Principles of Epidemiology in Public Health Practice (3rd ed.). Centers for Disease Control and Prevention. https://www.cdc.gov/csels/dsepd/ss1978/SS1978.pdf. Retrieved 11 April 2020.
- ↑ Hamilton, J.J.; Hopkins, R.S. (2019). "Chapter 5: Using Technologies for Data Collection and Management". In Rasmussen, S.A.; Goodman, R.A.. The CDC Field Epidemiology Manual (4th ed.). Oxford University Press. pp. 71–104. ISBN 9780190933692.
- ↑ von Elm, E.; Altman, D.G.; Egger, M. et al. (2007). "The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies". PLoS Medicine 4 (10): e296. doi:10.1371/journal.pmed.0040296. PMC PMC2020495. PMID 17941714. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020495.
- ↑ 5.0 5.1 Centers for Disease Control and Prevention (21 March 2020). "Information for Health Departments on Reporting Cases of COVID-19". Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/php/reporting-pui.html. Retrieved 21 March 2020.
- ↑ Government of Canada (10 February 2020). "Interim national surveillance guidelines for human infection with Coronavirus disease (COVID-19)". Government of Canada. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/interim-guidance-surveillance-human-infection.html. Retrieved 11 April 2020.
- ↑ European Centre for Disease Prevention and Control (2 March 2020). "Case definition and European surveillance for COVID-19, as of 2 March 2020". COVID-19 Portal. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/case-definition-and-european-surveillance-human-infection-novel-coronavirus-2019-ncov. Retrieved 11 April 2020.
- ↑ Green, C.; Bradley, V. (1 April 2020). "Coding guidance for new ICD-10-CM and lab testing codes for COVID-19". MGMA Stat. https://www.mgma.com/data/data-stories/coding-guidance-for-new-icd-10-cm-and-lab-testing. Retrieved 11 April 2020.
- ↑ AAP Division of Health Care Finance (12 March 2020). "How to use ICD-10-CM, new lab testing codes for COVID-19". American Academy of Pediatrics. https://www.aappublications.org/news/2020/03/12/coding031220. Retrieved 11 April 2020.
- ↑ El-Kareh, R.; Hasan, O.; Schiff, G.D. (2013). "Use of health information technology to reduce diagnostic errors". BMJ Quality & Safety 22 (Suppl. 2): ii40–ii51. doi:10.1136/bmjqs-2013-001884. PMC PMC3786650. PMID 23852973. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786650.
- ↑ National Academies of Sciences, Engineering, and Medicine (2015). "Chapter 5: Technology and Tools in the Diagnostic Process". Improving Diagnosis in Health Care. The National Academies Press. pp. 217–62. doi:10.17226/21794. ISBN 9780309377720. https://www.nap.edu/read/21794/chapter/7.
- ↑ 12.0 12.1 Winters-Miner, L.A.; Bolding, P.S.; Hilbe, J.M. et al. (2015). "Chapter 3: Biomedical Informatics". Practical Predictive Analytics and Decisioning Systems for Medicine. Academic Press. pp. 42–59. doi:10.1016/B978-0-12-411643-6.00003-X. ISBN 9780124116436.
- ↑ Mandl, K.D.; Overhage, J.M.; Wagner, M.M. et al. (2004). "Implementing syndromic surveillance: A practical guide informed by the early experience". JAMIA 11 (2): 141–50. doi:10.1197/jamia.M1356. PMC PMC353021. PMID 14633933. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC353021.